Drug Discrimination in Methadone-Maintained Humans Study 2
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Drug Discrimination in Methadone-Maintained Humans Study 2 is a clinical trial[1].
Key Facts
- Drug Discrimination in Methadone-Maintained Humans Study 2 is in the country of United States[2].
- Drug Discrimination in Methadone-Maintained Humans Study 2's instance of is recorded as clinical trial[3].
- Drug Discrimination in Methadone-Maintained Humans Study 2's start time is recorded as +2008-08-31T00:00:00Z[4].
- Drug Discrimination in Methadone-Maintained Humans Study 2's end time is recorded as +2010-10-31T00:00:00Z[5].
- Drug Discrimination in Methadone-Maintained Humans Study 2's sponsor is recorded as University of Arkansas[6].
- Drug Discrimination in Methadone-Maintained Humans Study 2's number of participants is recorded as {'unit': '1', 'amount': '+15'}[7].
- Drug Discrimination in Methadone-Maintained Humans Study 2's title is recorded as Drug Discrimination in Methadone-Maintained Humans Study 2[8].
- Drug Discrimination in Methadone-Maintained Humans Study 2's short name is recorded as OMDD2[9].
- Drug Discrimination in Methadone-Maintained Humans Study 2's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Drug Discrimination in Methadone-Maintained Humans Study 2's ClinicalTrials.gov ID is recorded as NCT00733239[11].
- Drug Discrimination in Methadone-Maintained Humans Study 2's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[12].
- Drug Discrimination in Methadone-Maintained Humans Study 2's research intervention is recorded as gabapentin[13].
- Drug Discrimination in Methadone-Maintained Humans Study 2's research intervention is recorded as methadone hydrochloride[14].
- Drug Discrimination in Methadone-Maintained Humans Study 2's research intervention is recorded as naloxone[15].
- Drug Discrimination in Methadone-Maintained Humans Study 2's research intervention is recorded as nifedipine[16].
- Drug Discrimination in Methadone-Maintained Humans Study 2's research intervention is recorded as verapamil[17].
- Drug Discrimination in Methadone-Maintained Humans Study 2's research intervention is recorded as diltiazem[18].
- Drug Discrimination in Methadone-Maintained Humans Study 2's research intervention is recorded as isradipine[19].
- Drug Discrimination in Methadone-Maintained Humans Study 2's research intervention is recorded as cycloserine[20].
- Drug Discrimination in Methadone-Maintained Humans Study 2's clinical trial phase is recorded as phase I clinical trial[21].
- Drug Discrimination in Methadone-Maintained Humans Study 2's research subject recruitment status is recorded as completed[22].
- Drug Discrimination in Methadone-Maintained Humans Study 2's study type is recorded as interventional study[23].